从药品生产质量管理规范违规行为中吸取的教训。 - Suppr

Lessons learned from good manufacturing practice noncompliance.

作者信息

Peskoe M P

机构信息

American Home Products Corporation, Madison, NJ, USA.

出版信息

Food Drug Law J. 1995;50(1):65-70.

PMID:10342986

Abstract

摘要

相似文献

Lessons learned from good manufacturing practice noncompliance.

Food Drug Law J. 1995;50(1):65-70.

The learned intermediary doctrine: past, present and future.

Leg Med. 1994:269-80.

Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.

Fed Regist. 2007 Dec 4;72(232):68064-70.

Quality control and good manufacturing practices: safety and efficacy of commercial herbals.

Food Drug Law J. 1997;52(3):341-4.

The federal preemption debate in pharmaceutical labeling product liability actions.

Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70.

A millstone in the uphill battle for credibility.

Altern Med Rev. 2001 Feb;6(1):3.

A defense of the learned intermediary doctrine.

Food Drug Law J. 2008;63(2):421-38.

The case for preemption of prescription drug failure-to-warn claims.

Food Drug Law J. 2007;62(2):399-422.

Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.

Food Drug Law J. 1995;50(4):553-67.

Vioxx, radiology, and the Food and Drug Administration.

J Am Coll Radiol. 2005 May;2(5):394-7. doi: 10.1016/j.jacr.2005.01.019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Lessons learned from good manufacturing practice noncompliance.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献